There is growing evidence that porcine reproductive and respiratory syndrome virus (PRRSV) has developed mechanisms to subvert the host innate immune response. PRRSV non-structural protein 2 (Nsp2) was suggested previously as a potential interferon (IFN) antagonist. This study focused on Nsp2 to investigate its inhibitory mechanism of IFN induction. It was demonstrated that Nsp2 strongly inhibited IFN-b production by antagonizing activation of the IFN regulatory factor 3 (IRF-3) pathway induced by the Sendai virus (SeV). Further studies revealed that the cysteine protease domain (PL2) of Nsp2 was necessary for IFN antagonism. Additionally, both full-length Nsp2 and the PL2 protease domain of Nsp2 were found to inhibit SeV-induced phosphorylation and nuclear translocation of IRF-3. These findings suggest that Nsp2 is likely to play an important role in subversion of IRF-3-dependent innate antiviral defences, providing a basis for elucidating the mechanisms underlying PRRSV pathogenesis.
INTRODUCTION
The production of type I interferons (IFN-a/b) plays a pivotal role in the host antiviral immune defence (Bonjardim, 2005) . Cellular sensors capable of recognizing various viral determinants initiate IFN signal transduction. Positive-stranded RNA viruses can generate intermediate dsRNA during replication, which is an efficient inducer of type I IFNs. This intermediate dsRNA can trigger a cascade of cellular sensors, resulting in type I IFN production and secretion (Kawai & Akira, 2006a; Randall & Goodbourn, 2008) . The induction of type I IFNs is initiated via recognition of a pathogen-associated molecule in dsRNA by cellular pattern recognition receptors, including Tolllike receptor 3 (TLR3), caspase recruitment domain (CARD)-containing proteins, retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 . TLR3 signals through the adaptor molecule Toll-interleukin-1-resistance domain-containing adaptor inducing IFN-b (TRIF), whilst MDA-5 and RIG-I signal through the adaptor molecule mitochondrial antiviral signal protein (MAVS; also known as IPS-1, Cardif and VISA) to activate a type I IFN response (Kawai & Akira, 2006b; Kawai et al., 2005; Yamamoto et al., 2003) . Despite utilizing different adaptors, both pathways converge to activate two downstream kinases, TANK-binding kinase 1 (TBK-1) and inhibitor of kB kinase e (IKKe), subsequently leading to the activation of latent IFN transcription factors, including IFN regulatory factors (IRF-3 and/or IRF-7), nuclear factor-kB (NF-kB) and activating protein 1 (AP-1) (Fitzgerald et al., 2003; Randall & Goodbourn, 2008; Sharma et al., 2003) . Activated IFN transcription factors translocate to the nucleus and activate IFN transcription (Biron, 2001) . Secreted IFN binds to the IFN receptor and activates a JAK/STAT signalling pathway, upregulating the expression of a subset of genes that impede virus replication (Randall & Goodbourn, 2008) . However, many viruses have evolved mechanisms to circumvent the IFN response (Blakqori et al., 2007; Jennings et al., 2005; Kopecky-Bromberg et al., 2007; Narayanan et al., 2008) .
There is mounting evidence that PRRSV infection subverts host immunity, suggesting that PRRSV has developed strategies to evade host immune responses. Previous studies have shown that PRRSV infection elicits only a minimal IFN response at the site of infection (Buddaert et al., 1998; Miller et al., 2004) . Moreover, swine IFN-b protects both PRRSV-permissive monkey kidney cells MARC-145 and porcine alveolar macrophages from PRRSV infection (Overend et al., 2007) . In addition, PRRSV inhibits the production of type I IFN induced by exogenous dsRNA (Luo et al., 2008; Miller et al., 2004) . PRRSV has also been found to diminish IFN-a production induced by infection with transmissible gastroenteritis coronavirus in porcine alveolar macrophages (Albina et al., 1998) . Recently, it was reported that PRRSV Nsp1, Nsp2, Nsp4 and Nsp11 can strongly antagonize IFN-b promoter activation (Beura et al., 2010; Chen et al., 2010a) . Detailed studies of Nsp1 (Nsp1a and Nsp1b) and Nsp11 have revealed that all three proteins strongly inhibited IFN synthesis (Beura et al., 2010; Chen et al., 2010a; Kim et al., 2010) . In addition, Nsp1b inhibited the JAK/STAT signalling pathway (Chen et al., 2010a) . However, the inhibitory mechanism of Nsp2 on IFN-b promoter activation remains to be defined. Nsp2 is a multifunctional protein, possessing a cysteine protease (PL2) domain, a central hypervariable region and a transmembrane domain (Han et al., 2006 (Han et al., , 2007 (Han et al., , 2009 Ziebuhr et al., 2000) . The PL2 protease domain of Nsp2 shares features of both papainlike cysteine proteases and chymotrypsin-like cysteine proteases, possessing both trans-and cis-cleavage activities (Han et al., 2009; Snijder et al., 1995) . Nsp2 aa 47-240 (Tyr47-Cys240) and Nsp2 aa 47-323 (Tyr47-Leu323) are required to maintain the trans-and cis-cleavage activities, respectively (Han et al., 2009) . The PL2 protease of PRRSV Nsp2 is thought to be a new member of the ovarian tumour (OTU) protease superfamily, capable of deconjugating ubiquitin and ISG15 (Frias-Staheli et al., 2007) . The highly conserved amino acids among OTU members are located at the putative Cys55-His124 catalytic motif of Nsp2. Moreover, it has been reported that immunodominant epitopes in Nsp2 play an important role in modulation of the host immune response (Chen et al., 2010b) . In this study, we have provided evidence that PRRSV Nsp2 inhibits IFN induction by antagonizing the activation of IRF-3. We also demonstrated that the PL2 protease domain of Nsp2 is necessary for antagonism of IRF-3 activation.
RESULTS

Nsp2 inhibits IFN-b induction
Previous investigations have suggested that PRRSV infection blocks IFN production (Beura et al., 2010; Buddaert et al., 1998; Lee et al., 2004; Miller et al., 2004) . Recently, Beura et al. (2010) reported that PRRSV Nsp2 is a strong antagonist of IFN-b promoter activation.
Here, we focused on Nsp2 to investigate whether it inhibits IFN-b induction. 293T cells were co-transfected with the reporter plasmid p125-Luc containing the IFN-b promoter, which drives expression of the firefly luciferase, the internal control plasmid phRL-TK and empty vector or constructs expressing candidate PRRSV proteins. A plasmid encoding the NS1 protein of influenza virus was used as a positive control for suppression of IFN induction. The cells were subsequently infected with the Sendai virus (SeV) for 16 h to stimulate IFN synthesis. As seen in Fig. 1(a) , expression of influenza virus NS1 protein strongly suppressed activation of the IFN-b promoter, as reported previously (García-Sastre, 2001; Kochs et al., 2007) . PRRSV Nsp2 protein from two strains, 07HBEZ and P129, strongly inhibited IFN-b promoter activation to a similar level (Fig. 1a) , despite that fact that these two Nsp2 proteins only have~83 % identity at the amino acid level. These results indicated that the PRRSV Nsp2 protein, regardless of its origin, can significantly suppress IFN-b promoter activation.
To further confirm the results generated from the IFN-b promoter reporter assay, we performed experiments to analyse IFN-b mRNA by real-time quantitative RT-PCR. 293T cells were transfected with empty vector or constructs expressing PRRSV strain 07HBEZ N, Nsp2 or influenza virus NS1 protein, followed by infection with SeV for 12 h. Total RNA was extracted and IFN-b mRNA was analysed by RT-PCR. As shown in Fig. 1(b) , both PRRSV Nsp2 and influenza virus NS1 strongly inhibited IFN-b mRNA synthesis induced by SeV, in agreement with results from the p125-Luc luciferase reporter assay, further indicating that Nsp2 protein inhibits IFN-b induction. The expression of PRRSV proteins was detected with anti-haemagglutinin (HA) mAb by Western blotting (Fig. 1c) .
Nsp2 inhibits the activation of IRF-3-and NF-kBresponsive promoters
It has been demonstrated that many viral IFN antagonists interfere with the IRF-3 and/or NF-kB signalling pathways (Basler et al., 2003; Boxer et al., 2009; Kochs et al., 2007; Kopecky-Bromberg et al., 2007) . We next determined the impact of Nsp2 expression on the IRF-3-or NF-kBdependent, SeV-induced activation of the IFN-b promoter. 293T cells were co-transfected with the construct PRD(III-I) 4 -Luc or NF-kB-Luc containing five repeats of the NFkB-binding element PRDII of the IFN-b promoter, and empty vector or Nsp2-expressing plasmid. Influenza virus NS1 was used as the positive control for inhibition of IRF-3 and NF-kB promoter activation. At 24 h post-transfection, the cells were stimulated with SeV for 16 h, followed by a luciferase assay. As shown in Fig. 2 , infection with SeV activated the IRF-3-and NF-kB-response promoters in cells transfected with the empty vector. The positive-control influenza virus NS1 protein inhibited expression from both IRF-3-and NF-kB-response promoters (Fig. 2a, b) . PRRSV Nsp2 expression also inhibited IRF-3- (Fig. 2a) and NF-kB- (Fig. 2b ) response promoter activation, indicating the possibility that Nsp2 can block both IRF-3-and NFkB-dependent IFN-b induction pathways. 
Nsp2 blocks activation of the IRF-3 pathway
As Nsp2 inhibited activation of the IRF-3-responsive promoters, we next investigated the factors associated with Nsp2 antagonism in the IRF-3-mediated pathway. Overexpression of individual components (RIG-I, MAVS, TBK-1, IKKe and IRF-3) of the IRF-3 signalling pathway can induce IFN-b gene expression. We therefore investigated the ability of Nsp2 to inhibit the activation of transcription from the IFN-b promoter induced by overexpression of the components. 293T cells were co-transfected with constructs encoding RIG-IN (RIG-I active mutant), MAVS, TBK-1, IKKe or IRF-3 along with reporter plasmid, internal control plasmid phRL-TK and empty vector or Nsp2 expression plasmid. As shown in Fig. 3 , overexpression of RIG-I, MAVS, TBK-1, IKKe or IRF-3 led directly to activation of the IFN-b promoter, in agreement with a previous report (Jaworska et al., 2007) . Expression of Nsp2 suppressed activation of the IFN-b promoter induced by the components of IRF-3 pathway in a dose-dependent fashion (Fig. 3) .
The PL2 protease domain of Nsp2 inhibits IFN-b induction
In searching for the function domain of Nsp2 that antagonizes IFN responses, we focused on the PL2 cysteine protease domain. In addition to its protease cleavage activity, Nsp2 PL2 protease is thought to be a new member of the OTU superfamily, having deubiquitination activity (FriasStaheli et al., 2007; Han et al., 2009) . As ubiquitination plays a pivotal role in the innate immune signalling pathway, we investigated whether the Nsp2 PL2 protease domain could regulate IFN induction. 293T cells were co-transfected with p125-Luc reporter plasmid and empty vector or a PL2 protease domain expression construct (Nsp2-PL2) containing the complete PL2 protease domain of Nsp2. Cells were subsequently infected with SeV to activate the IFN-b promoter. As shown in Fig. 4(a) , expression of PL2 protease inhibited activation of the IFN-b promoter induced by SeV.
We further investigated the impact of Nsp2-PL2 expression on IRF-3-or NF-kB-dependent, SeV-induced activation of the IFN-b promoter. 293T cells were transfected with PRD(III-I) 4 -Luc or NF-kB-Luc reporter construct along with empty vector or Nsp2-PL2 expression plasmid, followed by SeV treatment. As shown in Fig. 4(b, c) , expression of PL2 protease blocked activation of both IRF-3-and NF-kB-responsive promoters induced by SeV. As protein cellular location correlates with its function, we investigated the expression and subcellular localization of Nsp2-PL2. As shown in Fig. 4(d) , most Nsp2-PL2 was located in the cytoplasm, indicating that the subcellular location of Nsp2-PL2 is consistent with the cytoplasmic location of the full-length Nsp2. Both full-length Nsp2 and the PL2 protease domain inhibit SeV-induced IRF-3 phosphorylation and nuclear translocation
In response to cellular stimulation, activation of IRF-3 is achieved by phosphorylation of IRF-3. Upon phosphorylation, IRF-3 dimerizes and translocates to the nucleus, where it acts as a transcription factor. As both full-length Nsp2 and the PL2 protease domain inhibited IRF-3 pathway activation, we investigated whether they also inhibited SeVinduced IRF-3 phosphorylation and nuclear translocation. Phosphorylation of IRF-3 was analysed in cells transfected with empty vector or plasmid expressing full-length Nsp2 or the PL2 protease domain and infected with SeV to activate IRF-3. A plasmid encoding the NS1 protein of influenza virus was used as a positive control for inhibition of IRF-3 phosphorylation. As reported previously (Servant et al., 2003) , SeV infection rapidly triggered a noticeable increase in the level of IRF-3 phosphorylation, which was visualized using a specific anti-phospho-IRF-3 antibody (Fig. 6a) . As expected, expression of the full-length Nsp2 or PL2 protease domain inhibited SeV-induced phosphorylation of IRF-3 (Fig. 6a ). Nsp2 and PL2 expression did not change the level of total IRF-3, indicating that the decrease in IRF-3 phosphorylation was unlikely to have been caused by IRF-3 degradation.
Subsequently, nuclear translocation of IRF-3 was analysed in cells transfected with empty vector or plasmid expressing full-length Nsp2 or the PL2 protease domain and infected with SeV to stimulate IRF-3 translocation from the cytoplasm to the nucleus, by indirect immunofluorescence. When cells were incubated with 100 HAU SeV ml 21 for 8 h, almost all the cells were infected in terms of IRF-3 translocation to the nucleus. Hence, under these conditions, cells expressing PL2 or Nsp2 should be infected with SeV. As shown in Fig. 6(b) , IRF-3 located in the cytoplasm was translocated to the nucleus when the cells were infected with SeV. In contrast, SeV-induced IRF-3 translocation was blocked when cells were transfected with full-length Nsp2 or Nsp2-PL2 expression plasmid (Fig. 6b) . These data indicated that both full-length Nsp2 and the PL2 protease domain blocked IRF-3 nuclear translocation induced by SeV. was shown to suppress IFN production in vivo and in vitro (Miller et al., 2004; Rowland et al., 2001; Thanawongnuwech et al., 2001 ). More recently, five PRRSV non-structural proteins, Nsp1 (Nsp1a and Nsp1b), Nsp2, Nsp4 and Nsp11, were suggested as potential IFN antagonists as they inhibited activation of the IFN-b promoter (Beura et al., 2010) . Further investigation of Nsp1 showed that Nsp1 antagonizes both IFN synthesis and the signalling pathway (Beura et al., 2010; Chen et al., 2010a; Kim et al., 2010) .
In the present study, we demonstrated that Nsp2 inhibited IFN induction by blocking IRF-3 activation. In particular, Nsp2 inhibited SeV-induced IFN-b promoter activity and IFN-b mRNA synthesis. Furthermore, Nsp2 antagonized activation of the IRF-3 pathway and blocked phosphorylation and nuclear translocation of IRF-3 induced by SeV. In addition, we demonstrated that the PL2 cysteine protease domain of Nsp2 was responsible for the antagonism that blocked phosphorylation and nuclear translocation of IRF-3. IRF-3 plays a key role in the IFN induction pathway and is therefore an ideal target of many viruses in antagonizing the innate immune response. Many RNA viruses have evolved different mechanisms to inhibit IRF-3-mediated IFN induction. Some RNA viruses can block IRF-3 activation by inhibiting phosphorylation, dimerization and/or nuclear translocation of IRF-3. Others can induce proteasomedependent degradation of IRF-3. For example, Ebola virus VP35 protein and severe acute respiratory syndrome coronavirus (SARS-CoV) ORF3b, ORF6, N and papain-like protease (PLP) proteins inhibit IRF-3 activation (Basler et al., 2003; Clementz et al., 2010; Devaraj et al., 2007; Frieman et al., 2009; Kopecky-Bromberg et al., 2007) . Classical swine fever virus N pro and rotavirus NSP1 induce IRF-3 degradation (Bauhofer et al., 2007; Graff et al., 2007) .
Our findings also demonstrated that Nsp2 and the PL2 protease inhibited activation of the NF-kB-responsive promoter, probably affecting its respective pathway. During the preparation of this manuscript, Sun and coworkers reported that the PRRSV Nsp2 OTU domain inhibited NF-kB activation by interfering with the polyubiquitination process of IkBa . Moreover, PRRSV Nsp1b protein was recently reported to inhibit NF-kB-mediated gene induction (Beura et al., 2010) . In contrast, a previous report showed that PRRSV infection activated the NF-kB pathway through IkB degradation (Lee & Kleiboeker, 2005) . Considering that, in the study by Lee & Kleiboeker (2005) , activation of NFkB was assayed at a relatively late stage of PRRSV infection, a plausible explanation is that, during the early stage of The effect of Nsp2 and the PL2 protease domain on phosphorylation of IRF-3 was assayed by Western blotting. 293T cells were transfected with empty vector, full-length Nsp2 or PL2 domain of Nsp2 (Nsp2-PL2) expression construct. Influenza virus NS1 protein was used as a positive control for inhibition of IRF-3 phosphorylation. At 24 h posttransfection, cells were mock infected or infected with 100 HAU SeV ml "1 for 8 h. Phosphorylated IRF-3 (p-IRF-3) and total IRF-3 levels were measured with anti-IRF-3 or anti-p-IRF-3 antibody. b-Actin was used as a loading control. (b) The effect of Nsp2 and the PL2 protease domain on IRF-3 nuclear localization was determined by indirect immunofluorescence. 293T cells were transfected with empty vector, full-length Nsp2 or PL2 domain of Nsp2 (Nsp2-PL2) expression construct and then mock infected or infected with SeV for 8 h. Influenza virus NS1 was used as a positive control for the block of nuclear translocation of IRF-3. Cells were stained with mouse anti-HA mAb and rabbit anti-IRF-3 antibody. FITCconjugated goat anti-mouse (green) and TRITC-conjugated goat anti-rabbit (red) were used as the secondary antibody. Cell nuclei (blue) were stained with Hoechst 33258. The images were obtained by fluorescence microscopy using a ¾40 objective.
virus infection, the NF-kB pathway is inhibited by viral proteins to evade the innate immune response, whilst during the late stage of infection, virus activates the NF-kB pathway for cell survival through an anti-apoptotic mechanism.
PL2 cysteine proteases from arteriviruses have ubiquitin and ubiquitin-like deconjugating activity (Frias-Staheli et al., 2007) . Recently, the PRRSV PL2 protease was reported to possess both trans-and cis-cleavage activities (Han et al., 2009) . Interestingly, here we found that the PL2 cysteine protease domain of Nsp2 was responsible for IFN antagonism. This result is consistent with a previous report that PRRSV Nsp2 deconjugates ubiquitin and ISG15 from cellular target proteins (Frias-Staheli et al., 2007) . Therefore, the PL2 domain of Nsp2 not only acts as a viral protease and deubiquitinating (DUB) enzyme, but can also inhibit the induction of type I IFN. At present, we are unable to define the association between protease/DUB and IFN antagonism. A growing body of evidence suggests that ubiquitination plays a pivotal role in regulating the host innate response (Bhoj & Chen, 2009 ). RIG-I and IRF-3 have been identified as ubiquitin-targeted proteins (Gack et al., 2007; Zheng et al., 2008) . The ubiquitination of RIG-I catalysed by TRIM25 is necessary and sufficient to induce type I IFN synthesis (Bhoj & Chen, 2009 ). Activated IRF-3 could be polyubiquitinated during virus infection, and deubiquitinated IRF-3 fails to translocate to the nucleus, suggesting the possibility that IRF-3 activation may require ubiquitination (Saitoh et al., 2006; Zheng et al., 2008) . PRRSV and coronavirus, belonging to the order Nidovirales, have a similar genome organization. Several coronaviruses encode the cysteine proteases possessing deubiquitinating and IFN antagonism activities. For example, the PLP domains of human coronavirus, SARS-CoV and mouse hepatitis virus have DUB and IRF-3 antagonism activities (Barretto et al., 2005; Clementz et al., 2010; Devaraj et al., 2007; Frieman et al., 2009; Lindner et al., 2007; Zheng et al., 2008) . The study by Sun et al. (2010) revealed that the PRRSV Nsp2 OTU protease domain inhibits NF-kB activation by interfering with the polyubiquitination process of IkBa. However, a recent study suggested that there was a protease/DUB activity-independent mechanism by which coronavirus PLPs block IFN induction, although the protease and DUB activities of PLPs may contribute to IFN antagonism (Clementz et al., 2010) . In that study, it was also suggested that protease/DUB activity may be important for coronavirus PLP-mediated inhibition of NF-kB activity but is not essential for inhibition of IRF-3 activity. Further studies are needed to investigate whether PRRSV PL2 domain-mediated inhibition of IRF-3 activity requires the protease, DUB or ubiquitin-like activity.
PRRSV encodes multiple and different antagonists of IFN to subvert the host innate immune response. By rapidly impeding IFN-b gene induction, PRRSV infection results in a poor innate immune response, which accordingly affects the ensuing adaptive immune response, ultimately leading to the successful establishment of infection and subsequent persistence within the infected host. In conclusion, our investigations have demonstrated that the PRRSV Nsp2 protein is an IFN antagonist that blocks IFNb induction by antagonizing the activation of IRF-3. The PL2 protease domain of Nsp2 is necessary for the antagonism of IFN. Together, our data provide important insights into the mechanisms by which PRRSV Nsp2 protein subverts the host innate immune response.
METHODS
Cells and viruses. 293T and HeLa cells were maintained in Dulbecco's modified Eagle's medium (Gibco) supplemented with 10 % FBS at 37 uC with 5 % CO 2 . PRRSV strain 07HBEZ was isolated from the recent outbreaks of highly pathogenic PRRSV in China, and contained a discontinuous 30 aa deletion in the Nsp2 region (Tian et al., 2007; Zhou et al., 2009) . SeV was propagated in 10-day-old embryonated eggs, and the virus titre was determined by haemagglutination assay using chicken red blood cells.
Plasmids. Full-length Nsp2 and N genes were amplified from the cDNA of PRRSV 07HBEZ (GenBank accession nos FJ495082.2 and HM595639) (Han et al., 2007 (Han et al., , 2009 ). Full-length Nsp2 of strain P129 was amplified from plasmid pCMV-S-P129 . All genes were cloned into mammalian expression vector pCAGGS with an N-terminal HA tag. The N terminus (aa 1-323) of Nsp2 from strain 07HBEZ, including both complete PL2 protease and OTU domains, was subcloned into pCAGGS with an N-terminal HA tag (Han et al., 2007 (Han et al., , 2009 . The identity of the clones was verified by DNA sequencing. Expression of all proteins was confirmed by Western blotting using antibodies against the HA tag.
The reporter plasmid pNF-kB-Luc was purchased from Stratagene. The reporter plasmid p125-Luc (IFN-b-Luc) and expression plasmid pCAGGS-NS1 have been described previously (Kochs et al., 2007; Yoneyama et al., 1996) . The internal control plasmid phRL-TK was purchased from Promega. The IRF-3 expression plasmid was kindly provided by Dr Y. L. Lin (Chang et al., 2006) . pEF-flagRIG-IN (a Cterminally truncated, constitutively active RIG-I mutant) expression plasmid was kindly provided by Dr T. Fujita (Yoneyama et al., 2004) . pcDNA3-TBK1 and pcDNA3-IKKe expression plasmids were kind gifts from Dr K. Fitzgerald (Fitzgerald et al., 2003) . The reporter plasmid (PRDIII-I) 4 -Luc was kindly provided by Dr S. Ludwig (Ehrhardt et al., 2004) .
Transfection and reporter assay. 293T cells were seeded in 35 mm dishes and co-transfected with empty vector or plasmids encoding the PRRSV proteins, Renilla luciferase plasmid phRL-TK and reporter plasmid p125-Luc, PRD(III-I)4-Luc or pNF-kB-Luc. Transfections were carried out using calcium phosphate reagents according to the manufacturer's instructions (Promega). At 24 h post-transfection, cells were stimulated with 100 HAU SeV ml 21 for 16 h. Cells were harvested and lysed, and extracts were used to measure firey and Renilla luciferase activity using a Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol. For some experiments, 293T cells were co-transfected with empty vector, full-length Nsp2 or Nsp2-PL2 expression plasmid, reporter plasmid p125-Luc and Renilla luciferase plasmid phRL-TK, together with plasmid encoding IFN-b induction pathway elements RIG-IN, MAVS, TBK-1, IKKe or IRF-3. After 36 h, the enzymic activities of firefly and Renilla luciferase were measured.
Western blotting analysis. Following the indicated treatments/viral infections, cells were harvested and resuspended in lysis buffer (PBS with 1 % NP-40, 0.5 % deoxycholate, 0.1 % SDS and 1 mM EDTA) in the presence of Protease Inhibitor Cocktail (Sigma). Equal amounts of total proteins were separated by SDS-PAGE and Western blotting was performed as described previously (Kochs et al., 2007) . A mouse mAb against the HA tag (Beyotime) was used to detect expression of PRRSV proteins. For the IRF-3 phosphorylation experiment, a PVDF membrane was probed with rabbit anti-total IRF-3 or rabbit antiphospho-IRF-3 (Ser396) (Cell Signaling Technology). Protein bands were detected using an ECL detection system (Pierce).
Indirect immunouorescence. HeLa cells were seeded in 24-well plates and transfected with the indicated plasmid. At 24 h posttransfection, cells were mock infected or infected with SeV for 8 h, fixed with 4 % formaldehyde and permeabilized with 0.2 % Triton X-100. After three washes in PBS, the cells were blocked in PBS containing 3 % BSA and 2 % goat serum at 4 uC overnight. After three washes in PBS, the cells were incubated with rabbit polyclonal antiserum against human IRF-3 (diluted 1 : 300) or with anti-HA tag mAb (diluted 1 : 250) at 4 uC overnight. The cells were washed three times in PBS and then incubated with TRITC-conjugated goat antirabbit immunoglobulin (Pierce) and FITC-conjugated goat antimouse immunoglobulin (Pierce) for 1 h at 37 uC. The cells were washed three times in PBS and incubated with Hoechst 33258 for 10 min at room temperature, washed three times in PBS and observed under a fluorescence microscope (Olympus IX51).
Real-time quantitative RT-PCR analysis. 293T cells were seeded in 35 mm dishes and transfected with empty vector or plasmids encoding the PRRSV proteins. At 24 h post-transfection, cells were stimulated with SeV for 16 h. Cells were harvested and total RNA was extracted using TRIzol reagent (Invitrogen). Total RNA was reverse transcribed using Moloney murine leukemia virus reverse transcriptase and the cDNA was used for the amplification of IFN-b and GAPDH genes with the following primer pairs: IFN-b forward primer: 59-CAAATTGCTCTCCTGTTGTGCTTC-39; IFN-b reverse primer: 59-AATGCGGCGTCCTCCTTCT-39; GAPDH forward primer: 59-GAAGGTGAAGGTCGGAGTC-39; GAPDH reverse primer: 59-GAAGATGGTGATGGGATTTC-39. Quantitative PCR was performed on a LightCycler apparatus using a SYBR Green Real-time PCR Master Mix (Toyobo) dye. Standard curves were established with tenfold serial dilutions of the plasmids containing a GAPDH or IFN-b amplicon.
